Preliminary experiments show conolidine may perhaps inhibit precise ion channels, reducing neuronal excitability and limiting suffering indicators. This mechanism is particularly suitable in neuropathic discomfort, exactly where abnormal signaling triggers persistent pain. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathway